Jose Roberto Soares da Silva
Corporate Officer/Principal at BIOLAB SANUS Farmacêutica Ltda.
Jose Roberto Soares da Silva active positions
| Companies | Position | Start | End |
|---|---|---|---|
BIOLAB SANUS Farmacêutica Ltda.
 BIOLAB SANUS Farmacêutica Ltda. Pharmaceuticals: MajorHealth Technology BIOLAB is a Brazilian pharmaceutical corporation which develops, manufactures and commercializes medicines. BIOLAB is proud to be a benchmark in health products innovation. BIOLAB's core business is to produce prescription medicines in cardiology, rheumatology, orthopedics, general practice, pediatrics, endocrinology, geriatrics and dermatology. Following a global trend, they are massively investing in dermocosmetics, developing products to meet the requirements of the country's different weather characteristics, the different types of skin, and the use of natural resources from its biodiversity. BIOLAB is a leader in cardiovascular product prescriptions and ranks 8th in prescription drug sales. BIOLAB carries in its DNA the vocation for research, as a fundamental way for the development of new products and technologies. Since the company was founded, investment in research has allowed the launch of four exclusive products. | Corporate Officer/Principal | 2003-04-30 | - |
| Sales & Marketing | 2011-07-04 | - |
Career history of Jose Roberto Soares da Silva
Statistics
International
| Brazil | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
BIOLAB SANUS Farmacêutica Ltda.
BIOLAB SANUS Farmacêutica Ltda. Pharmaceuticals: MajorHealth Technology BIOLAB is a Brazilian pharmaceutical corporation which develops, manufactures and commercializes medicines. BIOLAB is proud to be a benchmark in health products innovation. BIOLAB's core business is to produce prescription medicines in cardiology, rheumatology, orthopedics, general practice, pediatrics, endocrinology, geriatrics and dermatology. Following a global trend, they are massively investing in dermocosmetics, developing products to meet the requirements of the country's different weather characteristics, the different types of skin, and the use of natural resources from its biodiversity. BIOLAB is a leader in cardiovascular product prescriptions and ranks 8th in prescription drug sales. BIOLAB carries in its DNA the vocation for research, as a fundamental way for the development of new products and technologies. Since the company was founded, investment in research has allowed the launch of four exclusive products. | Health Technology |
